ROSA DEL AGUILA PINEDA: Open Payments
NPI 1487293064 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$878 in 22 payments from 7 companies in 2025. Trend: 2023 $731 · 2024 $757 · 2025 $878
Food & beverage: $878
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $231 |
| Boston Scientific Corporation | 3 | $207 |
| AstraZeneca Pharmaceuticals LP | 3 | $154 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $153 |
| Edwards Lifesciences Corporation | 2 | $101 |
| Lilly USA, LLC | 1 | $16 |
| Cranial Technologies, Inc | 1 | $15 |
Products named: Ozempic, Kerendia, BREZTRI, WATCHMAN FLX, SAPIEN 3 Ultra RESILIA, LUX-Dx Insertable Cardiac Monitor, WaveWriter Alpha Prime 16, JARDIANCE.
Industry payments across AZ — which companies pay providers there.
